Feline Nasopharyngeal Stenosis

Feline nasopharyngeal stenosis (NPS) is a condition characterized by pathological narrowing or complete obstruction of the nasopharyngeal passage — the region connecting the nasal cavity to the pharynx — resulting in chronic upper airway obstruction. The stenosis is most commonly caused by the formation of a fibrous membrane or cicatricial scar tissue within the nasopharynx, which significantly restricts airflow [1]. Affected cats typically present with persistent stertor (low-pitched snoring or rattling upper airway noise) and increased inspiratory effort that can markedly impair quality of life [1]. Though relatively uncommon, it is an important differential diagnosis in cats with chronic upper airway signs, as it is frequently misdiagnosed or underdiagnosed without appropriate advanced imaging or endoscopy [2].

Primary Causes: Feline NPS is most commonly an acquired condition. The most frequently implicated underlying causes include:

• ·Chronic upper respiratory tract infection (URI): Viral pathogens such as feline herpesvirus-1 (FHV-1) and feline calicivirus (FCV) cause mucosal inflammation and ulceration that heal by secondary intention with fibrosis, eventually producing a stenotic membrane [2]
• ·Iatrogenic causes: Prolonged endotracheal intubation, nasogastric tube placement, or other nasopharyngeal instrumentation can cause mucosal trauma that heals with scarring [2]
• ·Post-inflammatory fibrosis: Any cause of sustained nasopharyngeal mucosal injury — including fungal rhinitis, severe bacterial rhinosinusitis, or foreign body reactions — may result in cicatricial stenosis
• ·Congenital cases: Rare congenital narrowing of the nasopharynx has been reported, as suggested by cases involving very young cats [3]

Pathological Mechanism: The central pathological process involves the formation of a fibrotic membrane or web within the nasopharyngeal lumen, typically at the level of the choanae or just caudal to them. This membrane is composed of dense fibrous connective tissue and may be partial (leaving a small residual lumen) or complete (causing total obstruction). The progressive reduction in nasopharyngeal cross-sectional area increases airway resistance in accordance with Poiseuille's law — resistance increases inversely with the fourth power of the luminal radius — meaning even modest reductions in diameter cause disproportionately large increases in resistance to airflow. This forces cats to breathe predominantly through the mouth or to exert greatly amplified inspiratory muscle effort, leading to the clinical signs observed [1][2].

Secondary changes include accumulation of mucus and debris rostral to the obstruction, predisposing to recurrent bacterial rhinosinusitis, and potentially contributing to middle or inner ear disease via eustachian tube dysfunction, as has been documented in at least one case involving concurrent otitis interna [3].

Clinical Evaluation: Diagnosis begins with a thorough history and physical examination, including auscultation of upper airways and careful evaluation of nasal airflow (e.g., using a glass slide or cotton wisp). Cats with NPS typically show markedly reduced or absent nasal airflow and audible stertor localized to the nasopharynx [1].

Diagnostic Imaging:

• ·Radiography: Lateral skull and nasopharyngeal radiographs may suggest NPS, though their sensitivity and specificity are limited. A recent study by Masuyama et al. (2025) specifically evaluated the diagnostic accuracy of radiography in feline NPS, describing characteristic radiographic findings that can help differentiate NPS-affected cats from those with other causes of stertor [1]. Findings may include soft-tissue opacity within the nasopharyngeal lumen or loss of the normal air column in this region.
• ·Computed Tomography (CT): CT provides superior cross-sectional anatomical detail and is highly valuable for defining the location, extent, and thickness of the stenotic membrane, as well as identifying concurrent abnormalities such as otitis interna or sinus disease. CT is recommended prior to intervention planning [3].

Rhinoscopy / Nasopharyngoscopy: Rhinoscopy — specifically retrograde nasopharyngoscopy using a flexible endoscope passed through the oral cavity — is considered the definitive diagnostic modality for NPS [1]. It allows direct visualization of the stenotic membrane or web, assessment of residual luminal diameter, and collection of biopsy specimens if needed. The procedure requires general anesthesia and careful airway management, particularly in cases of near-total obstruction [3].

Laboratory Diagnostics: There are no pathognomonic laboratory abnormalities specific to NPS. However, a baseline workup is recommended to rule out systemic disease and assess anesthetic risk:

• ·Complete blood count (CBC): May reveal leukocytosis with neutrophilia (elevated WBC) in cases complicated by secondary bacterial rhinosinusitis; HCT may be mildly elevated (polycythemia) as a compensatory response to chronic hypoxia in severe cases
• ·Serum biochemistry: BUN, CREA, ALT, ALB are generally within normal limits unless concurrent systemic disease is present; hypoalbuminemia (low ALB) may be noted in cats with prolonged anorexia or chronic infection
• ·Serology/PCR: Testing for FHV-1 and FCV may be informative when a viral etiology is suspected, though results must be interpreted cautiously given high background prevalence in the feline population
• ·Culture and sensitivity: Nasal or nasopharyngeal swab cultures can identify secondary bacterial pathogens to guide antibiotic therapy

Medical Management (Supportive/Palliative): Medical therapy alone cannot resolve NPS but may improve quality of life and control secondary infections:

• ·Antibiotics: Targeted based on culture and sensitivity results for secondary bacterial rhinosinusitis (e.g., doxycycline, amoxicillin-clavulanate)
• ·Antiviral therapy: Famciclovir may be considered if FHV-1 reactivation is contributing to ongoing inflammation
• ·Saline nebulization: Helps loosen secretions and improve mucociliary function
• ·Anti-inflammatory medications: Short courses of corticosteroids have been used to reduce post-procedural granulation tissue formation, though evidence is limited

Surgical / Interventional Treatments:

• ·Balloon dilation (Balloon catheter dilatation): The current first-line interventional treatment involves passage of a balloon catheter (typically through the nares or guided endoscopically) to mechanically dilate the stenotic segment. Multiple sessions are often required as re-stenosis is common.
• ·Membrane resection: Surgical resection of the fibrous membrane via a transoral or transnasal approach has been described. However, re-stenosis after simple resection is a significant concern [2].
• ·Intraluminal stenting: Novo and Kramek (1999) reported the use of a braided-wire endoprosthesis (stent) to maintain luminal patency following membrane resection in a cat with recurrent NPS [2]. The stent was 2 cm long and was placed following resection of the stenotic membrane. At the 19-week recheck, granulation tissue was found to be partially obstructing the pharyngeal aspect of the stent and required surgical resection, but the cat ultimately tolerated the stent well over long-term follow-up (evaluated up to 49 weeks post-procedure) [2]. Stenting represents an option for refractory or recurrent cases where repeated balloon dilation has failed.
• ·Combined approaches: Resection followed by balloon dilation or stenting may be employed in complex cases

Post-Procedural Care: Post-operative monitoring for respiratory distress, re-stenosis, granulation tissue formation, and secondary infection is essential. Periodic endoscopic re-evaluation is recommended, as re-stenosis can occur weeks to months after initial treatment [2].

NPS is generally a non-life-threatening condition in the short term, but chronic upper airway obstruction significantly impairs quality of life and can lead to serious complications if untreated, including severe respiratory distress and potentially life-threatening hypoxia in cases of near-complete obstruction [3].

Treatment Outcomes: Long-term prognosis is guarded to fair, heavily influenced by the tendency for re-stenosis following any interventional procedure. The case reported by Novo and Kramek (1999) demonstrated that intraluminal stenting could provide durable luminal patency, though granulation tissue formation required additional intervention at 19 weeks, and the cat required monitoring for at least 49 weeks post-procedure [2]. Recurrence following balloon dilation alone is well-recognized in clinical practice and often necessitates repeat procedures.

Mortality and Survival Statistics: Data on long-term population-level survival statistics and mortality rates specific to feline NPS are limited in current veterinary literature. No explicit peer-reviewed survival percentages or case-fatality rates for NPS were identified in the references cited above. The condition itself is not considered primarily fatal, but perioperative risks associated with anesthesia in a compromised airway patient, as well as the risks of severe chronic hypoxia in untreated cases, must be taken into account. Cases involving concurrent serious conditions (e.g., otitis interna, severe rhinosinusitis) may carry a more guarded prognosis [3].

Vaccination: There is no vaccine specifically targeting NPS itself. However, because chronic upper respiratory tract infections — particularly those caused by FHV-1 and FCV — are among the most important underlying causes, routine vaccination against these pathogens forms an indirect but important preventive strategy. Keeping cats current on core feline vaccines (FVRCP) may reduce the risk of severe mucosal injury that can lead to cicatricial stenosis.

Husbandry and Environmental Management:

• ·Minimize URI exposure: Reducing exposure to infectious agents through appropriate biosecurity in multi-cat households and catteries (e.g., quarantine of new arrivals, regular disinfection)
• ·Prompt treatment of upper respiratory infections: Early and appropriate management of acute URIs may reduce the severity of mucosal damage and subsequent fibrosis
• ·Careful peri-anesthetic airway management: Minimizing nasopharyngeal trauma during intubation, nasogastric tube placement, or other instrumentation, particularly in young or small cats, may reduce iatrogenic NPS risk [2]
• ·Regular veterinary monitoring: Cats with a history of severe URI or prior nasopharyngeal procedures should be monitored for early signs of airway obstruction so that intervention can be initiated before stenosis becomes severe
• ·Control of FHV-1 reactivation: In known FHV-1-positive cats, stress reduction and L-lysine supplementation (though evidence for lysine is debated) or antiviral prophylaxis may reduce recurrent mucosal inflammation